http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1100190-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62e63fdf4971b398f2123b1a902be754 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-108 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-38 |
| filingDate | 1965-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1968-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1100190-A |
| titleOfInvention | Somatic antigen vaccines |
| abstract | A process for the production of a "somatic antigen" vaccine comprises selecting bacteria, culturing the latter on a suitable nutrient medium, which includes an amino acid which is utilised in the formation of cell walls by said bacteria within the "critical concentration range", harvesting the resulting growth, inactivating and then lysing the bacteria. The "critical concentration range" of the amino acid is generally between 0.1-5.0% w./v. of the nutrient medium. It is defined as the range of concentration between the concentration above which the growth rate of a bacterium in a nutrient medium containing the amino acid starts to decrease and the concentration at which growth ceases. Specified amino acids are glycine, L-proline, DL-valine, L-histidine, DL-aspartic acid and L-arginine. Lysis may be carried out using a proteolytic enzyme. The examples relate to the preparation of meningococcus, staphylococcus, mastitis, streptococcus, and blackleg vaccines. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111254103-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111254103-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011265368-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011265368-B9 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006032475-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10548963-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006032475-A2 |
| priorityDate | 1964-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.